• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Jan 18, 1994; 91(2): 649–653.
PMCID: PMC43006

Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines.

Abstract

Molecular cloning studies have defined a family of dopamine D2-like receptors (D2, D3, and D4), which are the products of separate genes. Our previous work has shown that stimulation of dopamine D2-like receptors in cultures of fetal cortical neurons increases the extension and branching of neurites. To determine which D2-like receptors possess morphogenic potentials, a clonal mesencephalic cell line (MN9D) was transfected with D2, D3, or D4 receptor subtypes and treated with quinpirole, an agonist of D2-like receptors, and changes in morphological characteristics were quantitated. Stimulation of D2 receptors increased the number and branching of neurites with little effect on neurite extension; stimulation of D3 and D4 receptors increased the branching and extension of neurites. Similar results were found for primary mesencephalic cultures stimulated with quinpirole. These results suggest that the known D2-like receptors have specific developmental roles in regulating neuronal morphogenesis of dopaminergic pathways.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Mattson MP. Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. 1988 Apr-Jun;472(2):179–212. [PubMed]
  • Blanton MG, Lo Turco JJ, Kriegstein AR. Endogenous neurotransmitter activates N-methyl-D-aspartate receptors on differentiating neurons in embryonic cortex. Proc Natl Acad Sci U S A. 1990 Oct;87(20):8027–8030. [PMC free article] [PubMed]
  • LoTurco JJ, Blanton MG, Kriegstein AR. Initial expression and endogenous activation of NMDA channels in early neocortical development. J Neurosci. 1991 Mar;11(3):792–799. [PubMed]
  • Mattson MP, Murrain M, Guthrie PB, Kater SB. Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecture. J Neurosci. 1989 Nov;9(11):3728–3740. [PubMed]
  • Haydon PG, McCobb DP, Kater SB. Serotonin selectively inhibits growth cone motility and synaptogenesis of specific identified neurons. Science. 1984 Nov 2;226(4674):561–564. [PubMed]
  • Chubakov AR, Gromova EA, Konovalov GV, Sarkisova EF, Chumasov EI. The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture. Brain Res. 1986 Mar 26;369(1-2):285–297. [PubMed]
  • Hauser KF, McLaughlin PJ, Zagon IS. Endogenous opioids regulate dendritic growth and spine formation in developing rat brain. Brain Res. 1987 Jul 21;416(1):157–161. [PubMed]
  • Feigenbaum JJ, Yanai J. Normal and abnormal determinants of dopamine receptor ontogeny in the central nervous system. Prog Neurobiol. 1984;23(3):191–225. [PubMed]
  • Sales N, Martres MP, Bouthenet ML, Schwartz JC. Ontogeny of dopaminergic D-2 receptors in the rat nervous system: characterization and detailed autoradiographic mapping with [125I]iodosulpride. Neuroscience. 1989;28(3):673–700. [PubMed]
  • Mack KJ, O'Malley KL, Todd RD. Differential expression of dopaminergic D2 receptor messenger RNAs during development. Brain Res Dev Brain Res. 1991 Apr 24;59(2):249–251. [PubMed]
  • Lankford KL, DeMello FG, Klein WL. D1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: evidence that neurotransmitters act as morphogenic growth regulators in the developing central nervous system. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4567–4571. [PMC free article] [PubMed]
  • Choi HK, Won LA, Kontur PJ, Hammond DN, Fox AP, Wainer BH, Hoffmann PC, Heller A. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 1991 Jun 21;552(1):67–76. [PubMed]
  • Choi HK, Won L, Roback JD, Wainer BH, Heller A. Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):8943–8947. [PMC free article] [PubMed]
  • O'Malley KL, Mack KJ, Gandelman KY, Todd RD. Organization and expression of the rat D2A receptor gene: identification of alternative transcripts and a variant donor splice site. Biochemistry. 1990 Feb 13;29(6):1367–1371. [PubMed]
  • Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 1990 Sep 13;347(6289):146–151. [PubMed]
  • O'Malley KL, Harmon S, Tang L, Todd RD. The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biol. 1992 Feb;4(2):137–146. [PubMed]
  • Sikich L, Hickok JM, Todd RD. 5-HT1A receptors control neurite branching during development. Brain Res Dev Brain Res. 1990 Nov 1;56(2):269–274. [PubMed]
  • Owens GC, Johnson R, Bunge RP, O'Malley KL. L-3,4-dihydroxyphenylalanine synthesis by genetically modified Schwann cells. J Neurochem. 1991 Mar;56(3):1030–1036. [PubMed]
  • Sokoloff P, Andrieux M, Besançon R, Pilon C, Martres MP, Giros B, Schwartz JC. Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol. 1992 Apr 10;225(4):331–337. [PubMed]
  • Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991 Apr 18;350(6319):610–614. [PubMed]
  • Fiszman ML, Zuddas A, Masana MI, Barker JL, di Porzio U. Dopamine synthesis precedes dopamine uptake in embryonic rat mesencephalic neurons. J Neurochem. 1991 Feb;56(2):392–399. [PubMed]
  • Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M, Machida CA, Neve KA, Civelli O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature. 1988 Dec 22;336(6201):783–787. [PubMed]
  • Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 1986 Jan;43(1):31–35. [PubMed]
  • Jeste DV, Lohr JB. Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry. 1989 Nov;46(11):1019–1024. [PubMed]
  • Pfefferbaum A, Zipursky RB, Lim KO, Zatz LM, Stahl SM, Jernigan TL. Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia. Arch Gen Psychiatry. 1988 Jul;45(7):633–640. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...